VG801
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for VG801, covering 2025-12-11 to 2025-12-11. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Preliminary Efficacy of VG801 in Patients With ABCA4 Mutation-associated Retinal Dystrophy (Stargardt Disease) [Phase 1, Phase 2]